Ventana Enters into Agreement with Merck KGaA

News   Jul 12, 2014

 
Ventana Enters into Agreement with Merck KGaA
 
 
 

RELATED ARTICLES

Blood Cancers are Outsmarting the Immune System, But How?

News

Researchers have discovered how some of the blood cancers known as myeloproliferative neoplasms (MPNs) evade the immune system.

READ MORE

Lonza Expands Encapsulation and HPAPI Capabilities in North America

News

Expanding our capabilities into commercial-scale encapsulation responds to our customers' desire to maintain programs at the Tampa, FL (USA) site from clinical development to commercialization.

READ MORE

Shire, Microsoft and EURORDIS Form Global Commission to Accelerate Rare Disease Diagnosis

News

The alliance aims to shorten the often multi-year journey that patients and families endure before being diagnosed with a rare disease.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE